title: Scleromyxedema secondary to hepatitis C virus and successfully treated with antiviral therapy.
abstract: Scleromyxedema (SM) is a chronic and progressive fibromucinous disease with no known etiology. We report a patient with scleromyxedema associated with hepatitis C virus, successfully treated with interferon and ribavirin therapy.
authors.affiliation: Oregon Health and Science University. jessasmith1986@gmail.com.
authors.forename: J A
authors.initials: JA
authors.lastname: Smith
authors.forename: F A
authors.initials: FA
authors.lastname: Kalimullah
authors.forename: C P
authors.initials: CP
authors.lastname: Erickson
authors.forename: L S
authors.initials: LS
authors.lastname: Peng
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D016174:Hepacivirus; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use*; D053718:Scleromyxedema / Q000188:drug therapy* / Q000473:pathology / Q000821:virology*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a